Evidence map›Paper›PMID 37507871›Full record

ArticleAntioxidants (Basel, Switzerland)2023

Novel Acylselenourea Derivatives: Dual Molecules with Anticancer and Radical Scavenging Activity.

Nora Astrain-Redin, Asif Raza, Ignacio Encío, Arun K Sharma, Daniel Plano, Carmen Sanmartín

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nora Astrain-RedinDepartamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0001-8593-8994
Asif RazaDepartment of Pharmacology, Penn State Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA.ORCID 0000-0002-5716-7202
Ignacio EncíoInstituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea, 3, 31008 Pamplona, Spain.ORCID 0000-0003-1732-1989
Arun K SharmaDepartment of Pharmacology, Penn State Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA.ORCID 0000-0002-7679-7779
Daniel PlanoDepartamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-8266-0445
Carmen SanmartínDepartamento de Tecnología y Química Farmacéuticas, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0003-3431-7826

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress surrounding cancer cells provides them with certain growth and survival advantages necessary for disease progression. In this context, Se-containing molecules have gained attention due to their anticancer and antioxidant activity. In our previous work, we synthesized a library of 39 selenoesters containing functional groups commonly present in natural products (NP), which showed potent anticancer activity, but did not demonstrate high radical scavenger activity. Thus, 20 novel Se derivatives resembling NP have been synthesized presenting acylselenourea functionality in their structures. Radical scavenger activity was tested using DPPH assay and in vitro protective effects against ROS-induced cell death caused by H

Indexed as

acylselenoureaantioxidantcancergarlicnatural productsselenium

Identifiers

PMID37507871
PMCPMC10376326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.